Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held, clinical stage gene therapy platform company dedicated to improving the lives of children and adults with rare genetic disorders. AskBio’s gene therapy platform includes an industry-leading proprietary cell line manufacturing process known as Pro10, an extensive AAV capsid library, and synthetic promoter technology. The company has generated hundreds of proprietary third generation gene vectors, several of which have entered clinical testing, and maintains a portfolio of development programs across a range of indications, including Pompe, Limb Girdle Muscular Dystrophy, Cystic Fibrosis, Myotonic Muscular Dystrophy and Huntington’s; other programs that use AskBio’s technology include Hemophilia (Chatham Therapeutics/Takeda) and Duchenne Muscular Dystrophy (Bamboo Therapeutics/Pfizer). For more information, visit www.askbio.com.

Address

20 TW Alexander Drive, Suite 110, Research Triangle Park, NC 27709
RTP, NC 27709

Get In Touch

General Contact:
919-299-6602
krenfroe@askbio.com